financetom
Business
financetom
/
Business
/
UnitedHealth's unit reduces renewal requirements for some prescription drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UnitedHealth's unit reduces renewal requirements for some prescription drugs
Mar 19, 2025 5:58 AM

March 19 (Reuters) - UnitedHealth Group's ( UNH )

pharmacy benefit manager, Optum Rx, said on Wednesday it would

ease requirements to get insurance authorization when renewing

prescriptions on about 80 drugs, aiming to reduce the paperwork

for patients and doctors.

The list, which could be expanded over time, will eliminate

up to 25% of these reauthorization requirements and accounts for

more than 10% of all such pharmacy authorizations, it said.

The killing of a UnitedHealth ( UNH ) executive last December had

set off an outpouring of complaints about insurance on social

media, including its and other health insurers' requirements to

seek their approval on medicines.

In January this year, UnitedHealth ( UNH ) said during a conference

call with investors that it would work with policymakers to

reduce the frequency of prior authorizations required before a

patient can access medical treatment in its Medicare business

for people aged 65 and older or with disabilities.

Reauthorizations, or certain checks that patients need to go

through to continue receiving their medications, are necessary

for drugs that have safety concerns, or need ongoing monitoring

for adjusting doses, or additional tests, UnitedHealth's ( UNH ) unit

said.

Newly approved drugs for diseases such as Alzheimer's

require ongoing review, whereas with genetic conditions like

cystic fibrosis, there is minimal additional value in

reauthorizing a treatment, the company said.

Pharmacy benefit managers negotiate drug prices and create

coverage lists for health plans, mainly for employers and the

government. They pay pharmacies directly for prescription drugs

under their agreed terms.

CVS Health's ( CVS ) Caremark, Cigna's ( CI ) Express

Scripts and UnitedHealth's ( UNH ) Optum control the majority of the

U.S. pharmacy benefit market, with their parent companies also

operating health insurance and pharmacy businesses.

They have come under scrutiny for their role in driving up

costs for drugs, and President Donald Trump has also said he

wants to knock out these middlemen.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcturus Therapeutics Holdings Insider Sold Shares Worth $610,574, According to a Recent SEC Filing
Arcturus Therapeutics Holdings Insider Sold Shares Worth $610,574, According to a Recent SEC Filing
Mar 27, 2024
04:22 PM EDT, 03/27/2024 (MT Newswires) -- Pad Chivukula, Chief Scientific Officer & COO, on March 25, 2024, sold 17,435 shares in Arcturus Therapeutics Holdings ( ARCT ) for $610,574. Following the Form 4 filing with the SEC, Chivukula has control over a total of 473,448 shares of the company, with 473,448 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000452/xslF345X03/e663461_4-chivukula.xml ...
H.B. Fuller Fiscal Q1 Adjusted Earnings, Revenue Rise
H.B. Fuller Fiscal Q1 Adjusted Earnings, Revenue Rise
Mar 27, 2024
04:25 PM EDT, 03/27/2024 (MT Newswires) -- H.B. Fuller ( FUL ) reported fiscal Q1 adjusted earnings Wednesday of $0.67 per diluted share, up from $0.55 a year earlier. Analysts polled by Capital IQ expected $0.63. Net revenue for the quarter ended March 2 was $810.4 million, up from $809.2 million a year earlier. Analysts surveyed by Capital IQ expected...
Jpmorgan Chase Insider Sold Shares Worth $765,805, According to a Recent SEC Filing
Jpmorgan Chase Insider Sold Shares Worth $765,805, According to a Recent SEC Filing
Mar 27, 2024
04:21 PM EDT, 03/27/2024 (MT Newswires) -- Lori A Beer, Chief Information Officer, on March 25, 2024, sold 3,920 shares in Jpmorgan Chase ( JPM ) for $765,805. Following the Form 4 filing with the SEC, Beer has control over a total of 64,783 shares of the company, with 64,783 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19617/000122520824004562/xslF345X03/doc4.xml Price: 199.28, Change: -0.24,...
Ally Financial names Michael Rhodes as CEO
Ally Financial names Michael Rhodes as CEO
Mar 27, 2024
March 27 (Reuters) - Ally Financial ( ALLY ) said on Wednesday it has appointed Michael Rhodes as chief executive officer. Rhodes most recently served as the CEO of Discover Financial Services ( DFS ). ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved